Open AccessCOVID-19-Vaccination Prioritization in Patients with Cancer
Publication year - 2021
Publication title -
journal of bioscience and biomedical engineering
Language(s) - English
Resource type - Journals
ISSN - 2693-2504
DOI - 10.47485/2693-2504.1055
Subject(s) - medicine , seroconversion , cancer , covid-19 , vaccination , immunology , transplantation , oncology , antibody , disease , infectious disease (medical specialty)
In patients with cancer, SARS-CoV-2 (COVID-19) can contribute to increasing morbidity and mortality and decreased survival was found in patients with hematological and intrathoracic malignancies, poor performance status, comorbidities, and increasedage. Patients with hematological malignancies who were treated with stem cell transplantation and anti-CD-20 antibody demonstrated lower rates of seroconversion, compared to COVID-19-infected-cancer patients. Patients with hematologicalmalignancies might have substantially compromised B-cell and T-cell responses.